Start Date
May 31, 2014
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
BKM120
NVP-BKM120 (BKM120) is an oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor belonging to the 2,6-dimorpholino pyrimidine derivative family.Supplied in 10mg or 50mg capsules. Starting dose: 100mg Once Daily
Huntsman Cancer Institute, Salt Lake City
Collaborators (1)
Novartis
INDUSTRY
University of Utah
OTHER